Cite
Ferastraoaru D, Bax HJ, Bergmann C, et al. AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI). Clin Transl Allergy. 2020;10:32doi: 10.1186/s13601-020-00335-w.
Ferastraoaru, D., Bax, H. J., Bergmann, C., Capron, M., Castells, M., Dombrowicz, D., Fiebiger, E., Gould, H. J., Hartmann, K., Jappe, U., Jordakieva, G., Josephs, D. H., Levi-Schaffer, F., Mahler, V., Poli, A., Rosenstreich, D., Roth-Walter, F., Shamji, M., Steveling-Klein, E. H., Turner, M. C., Untersmayr, E., Karagiannis, S. N., & Jensen-Jarolim, E. (2020). AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI). Clinical and translational allergy, 1032. https://doi.org/10.1186/s13601-020-00335-w
Ferastraoaru, D, et al. "AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)." Clinical and translational allergy vol. 10 (2020): 32. doi: https://doi.org/10.1186/s13601-020-00335-w
Ferastraoaru D, Bax HJ, Bergmann C, Capron M, Castells M, Dombrowicz D, Fiebiger E, Gould HJ, Hartmann K, Jappe U, Jordakieva G, Josephs DH, Levi-Schaffer F, Mahler V, Poli A, Rosenstreich D, Roth-Walter F, Shamji M, Steveling-Klein EH, Turner MC, Untersmayr E, Karagiannis SN, Jensen-Jarolim E. AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI). Clin Transl Allergy. 2020 Jul 17;10:32. doi: 10.1186/s13601-020-00335-w. eCollection 2020. PMID: 32695309; PMCID: PMC7366896.
Copy
Download .nbib